What is cancer nanotechnology?
Cancer nanotechnology has the potential to dramatically improve current approaches to cancer detection, diagnosis, imaging, and therapy while reducing toxicity associated with traditional cancer therapy (1, 2). In this overview, we will define cancer nanotechnology, consider issues related to application of nanotechnology for cancer imaging and therapy, and broadly consider implications for continued development in nanotechnology for the future of clinical cancer care. These considerations will place in perspective the methodological approaches in cancer nanotechnology and subject reviews outlined in this volume.
Grobmyer
Stephen R
SR
Division of Surgical Oncology, Department of Surgery, University of Florida, Gainesville, Florida, USA.
Iwakuma
Nobutaka
N
Sharma
Parvesh
P
Moudgil
Brij M
BM
D000818:Animals; D003287:Contrast Media; D003952:Diagnostic Imaging; D016503:Drug Delivery Systems; D006801:Humans; D053758:Nanoparticles / Q000633:toxicity; D036103:Nanotechnology / Q000379:methods*; D009369:Neoplasms / Q000175:diagnosis* / Q000628:therapy*
D003287:Contrast Media